Dys-synchronous regulation of XPC and XPA in trigeminal ganglion neurons following cisplatin treatment cycles

Keyphrases

• Cis-diamminedichloroplatinum 100%
• Treatment Cycle 100%
• Synchronous Regulation 100%
• Trigeminal Ganglion Neurons 100%
• Vulnerability 33%
• Immunoreactivity 33%
• HyPer 33%
• DNA Damage 16%
• Immunohistochemistry 16%
• Chemotherapy 16%
• Cancer Cells 16%
• Immunolocalization 16%
• 2-cycles 16%
• Neuronal Cells 16%
• DNA Repair Enzymes 16%
• Xeroderma pigmentosum 16%
• Second-line Treatment 16%
• Trigeminal Ganglion 16%
• Non-cancer 16%
• Peripheral Neurotoxicity 16%
• Peripheral Neurons 16%

Neuroscience

• Trigeminal Ganglion 100%
• Immunohistochemistry 50%
• DNA Damage 50%
• DNA Repair 50%
• Neurotoxicity 50%

Nursing and Health Professions

• Cisplatin 100%
• Malignant Neoplasm 16%
• Immunolocalization 16%
• Neurotoxicity 16%
• Xeroderma pigmentosum 16%
• Immunohistochemistry 16%